HighRes Biosolutions, the leader in laboratory automation solutions for life science, announced today that it has joined the Standardization in Lab Automation (SiLA) consortium.
The SiLA consortium for Standardization in Lab Automation is developing new device and data interface standards, with the aim of allowing rapid integration of lab automation and data management systems. Leading system manufacturers, software suppliers, system integrators and pharmaceutical/biotech corporations form the SiLA consortium.
“Since our inception, HighRes has believed that modularity and flexibility are keys to successful and productive laboratory automation. As a supplier of everything from integrated systems to instruments to software, we understand that industry standards make this ideal easier to realize,” said HighRes Biosolutions Managing Director Ira Hoffman. “Coupled with MicroDocks, our patented modular docking technology, and our dynamic scheduler Cellario, we hope these new standards will mean that scientists will be able to integrate innovative new technologies into their automated systems even faster.”
“We are very happy to welcome HighRes Biosolutions as a new corporate member of the SiLA consortium,” said Dieter Speidel, Chief Technology Officer of SiLA. “We are looking forward to working with HighRes’ highly experienced team in our various technical workgroups and upcoming integration projects.”
About HighRes Biosolutions
HighRes Biosolutions, Inc. is the leader in the design and construction of innovative robotic systems and laboratory devices used by pharmaceutical, biotech, and academic research laboratories. HighRes accelerates drug discovery, high throughput genotyping, siRNA screening, next-generation sequencing sample prep, biorepository science and molecular diagnostics with highly flexible, expandable and modular integrated systems, bench-top devices and consumables that are easily configured (and reconfigured) to create research environments conducive to achieving breakthrough results.